Prolia

Amgen sues Samsung biotech unit over bone drug copies
Reuters
Tue, 08/13/24 - 11:08 pm
Amgen
Samsung
biologics
biosimilars
legal
Prolia
Xgeva
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Sandoz
biosimilars
FDA
Amgen
denosumab
Prolia
Jubbonti
Xgeva
Wyost
Amgen’s Prolia Gets FDA Boxed Warning for Risk of Severe Hypocalcemia
Xtalks
Sun, 01/28/24 - 06:28 pm
Amgen
Prolia
hypocalcemia
FDA
warnings
osteoporosis
FDA adds 'boxed warning' for Amgen's Prolia
Reuters
Fri, 01/19/24 - 11:26 am
Amgen
Prolia
FDA
warnings
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Wed, 05/3/23 - 10:41 pm
Amgen
Sandoz
legal
Prolia
Xgeva
patents
denosumab
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Wed, 04/5/23 - 07:15 pm
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Sandoz files biosimilar of Amgen osteoporosis drug in US
Pharmaphorum
Tue, 02/7/23 - 12:22 pm
Sandoz
Novartis
biosimilars
osteoporosis
Prolia
Xgeva
FDA
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Pharmaceutical Business Review
Tue, 07/23/19 - 10:03 am
Novartis
Sandoz
biosimilars
clinical trials
denosumab
osteoporosis
Prolia
Xgeva
Consumer watchdog petitions FDA for black box warning on Amgen's Prolia
Fierce Pharma
Fri, 04/19/19 - 06:14 pm
FDA
osteoporosis
Amgen
Prolia
spinal fractures
Public Citizen
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Fierce Pharma
Tue, 05/22/18 - 06:06 pm
Amgen
FDA
Aimovig
migraines
Prolia
Amgen focuses on migraine launch as growth remains slow
Biopharma Dive
Wed, 04/25/18 - 10:54 pm
Amgen
earnings
Repatha
Kyprolis
Prolia
Xgeva
What to Expect From Amgen, Inc. in 2018
Motley Fool
Sun, 01/21/18 - 10:40 am
Amgen
Enbrel
Neulasta
Aranesp
Epogen
Neupogen
Prolia
Repatha
CAR-T
5 Things Amgen's CEO Just Said That Investors Need to Know
Motley Fool
Wed, 01/10/18 - 10:13 am
Amgen
Pharma CEOs
Bob Bradway
Prolia
M&A
Amgen rolls new Prolia osteoporosis ads, just weeks after next-gen Evenity hits a snag
Fierce Pharma
Wed, 08/16/17 - 09:39 pm
Amgen
Prolia
osteoporosis
drug ads
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Tue, 09/20/16 - 09:51 am
Amgen
Dr Reddy's
India
Xgeva
Prolia
Vectibix
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Market Realist
Sat, 07/30/16 - 09:53 pm
Amgen
Prolia
Xgeva
osteoporosis
Can Amgen’s Prolia Continue Its Strong Growth Trajectory in 2016?
Yahoo/Market Realist
Thu, 05/19/16 - 03:29 pm
Amgen
Prolia
9 Drugs That Cost Medicare a Fortune
Motley Fool
Sun, 04/10/16 - 01:29 pm
Medicare
Lucentis
Eylea
Prolia
Treanda
Lexiscan
Yervoy
Privigen
Provenge
Soliris
How Could Prolia Drive Amgen’s Valuations in 2016?
Yahoo/Market Realist
Wed, 03/23/16 - 04:08 pm
Prolia
Amgen

Pages